Literature DB >> 817854

Mitogenicity of Corynebacterium parvum for mouse lymphocytes.

H Zola.   

Abstract

Corynebacterium parvum, a powerful in vivo immunostimulant, is shown to stimulate lymphocyte proliferation in vitro. C. parvum is mitogenic for B lymphocytes and does not stimulate T cells. The mitogenicity is dependent on the presence of macrophages. C. diphtheriae and another strain of C. parvum, both of which are devoid of adjuvant, RES stimulation, and tumour-inhibiting activities in vivo are nevertheless mitogenic. A lipid-free fraction from C. parvum, which retains in vivo immunostimulatory properties, is not mitogenic. Thus the mitogenic property is not correlated with the in vivo properties of C. parvum.

Entities:  

Mesh:

Substances:

Year:  1975        PMID: 817854      PMCID: PMC1538433     

Source DB:  PubMed          Journal:  Clin Exp Immunol        ISSN: 0009-9104            Impact factor:   4.330


  13 in total

Review 1.  Role of antigen structure in the discrimination between tolerance and immunity by b cells.

Authors:  M Feldmann; J G Howard; C Desaymard
Journal:  Transplant Rev       Date:  1975

2.  Mechanisms of macrophage activation by corynebacterium parvum. II. In vivo experiments.

Authors:  R Bomford; G H Christie
Journal:  Cell Immunol       Date:  1975-05       Impact factor: 4.868

3.  Separation of T and B lymphocytes by nylon wool columns: evaluation of efficacy by functional assays in vivo.

Authors:  D Trizio; G Cudkowicz
Journal:  J Immunol       Date:  1974-10       Impact factor: 5.422

4.  A rapid method for the isolation of functional thymus-derived murine lymphocytes.

Authors:  M H Julius; E Simpson; L A Herzenberg
Journal:  Eur J Immunol       Date:  1973-10       Impact factor: 5.532

5.  The effect of Corynebacterium parvum on the structure and function of the lymphoid system in mice.

Authors:  J E Castro
Journal:  Eur J Cancer       Date:  1974-02       Impact factor: 9.162

6.  Biological effects of Corynebacterium parvum. IV. Adjuvant and inhibitory activities on B lymphocytes.

Authors:  J G Howard; G H Christie; M T Scott
Journal:  Cell Immunol       Date:  1973-05       Impact factor: 4.868

7.  Biological effects of the adjuvant Corynebacterium parvum. I. Inhibition of PHA, mixed lymphocyte and GVH reactivity.

Authors:  M T Scott
Journal:  Cell Immunol       Date:  1972-11       Impact factor: 4.868

8.  Depression of delayed hypersensitivity by pretreatment with Freund-type adjuvants. I. Description of the phenomenon.

Authors:  G L Asherson; G G Allwood
Journal:  Clin Exp Immunol       Date:  1971-08       Impact factor: 4.330

9.  A miniaturized mouse mixed leukocyte culture in serum-free and mouse serum supplemented media.

Authors:  A B Peck; F H Bach
Journal:  J Immunol Methods       Date:  1973-10       Impact factor: 2.303

10.  Lympho-reticular stimulatory properties of Corynebacterium parvum and related bacteria.

Authors:  C Adlam; M T Scott
Journal:  J Med Microbiol       Date:  1973-08       Impact factor: 2.472

View more
  5 in total

1.  Interferon production and lymphocyte stimulation in human leucocyte cultures stimulated by Corynebacterium parvum.

Authors:  H M Hirt; M Schwenteck; H Becker; H Kirchner
Journal:  Clin Exp Immunol       Date:  1978-06       Impact factor: 4.330

2.  Polyclonal activation of human lymphocytes by bacteria.

Authors:  L Räsänen; E Karhumäki; R Majuri; H Arvilommi
Journal:  Infect Immun       Date:  1980-05       Impact factor: 3.441

3.  Experimental intraocular malignancy: the effect of intracameral perfusion.

Authors:  V G Wong; W R Green; Y P Liu; E R Marsden
Journal:  Trans Am Ophthalmol Soc       Date:  1979

4.  Effect of pretreatment with Bacillus Calmette-Guerin on the course of a Listeria monocytogenes infection in normal and congenitally athymic (nude) mice.

Authors:  E J Ruitenberg; L M Van Noorle Jansen; W Kruizinga; P A Steerenberg
Journal:  Br J Exp Pathol       Date:  1976-06

5.  Paradoxical presence of T cell anergy during successful T cell-dependent tumour immunotherapy: characterization of a state of T cell 'amnaesia' following systemic administration of C. parvum.

Authors:  W H McBride; S Howie
Journal:  Clin Exp Immunol       Date:  1984-07       Impact factor: 4.330

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.